Changes in the gut microbiome before rheumatoid arthritis is developed could provide a window of opportunity for preventative treatments, new research suggests.

As of 2020, about 17.6 million people globally were living with rheumatoid arthritis, an autoimmune disease causing painful ...

Tofacitinib (Xeljanz): Used for rheumatoid arthritis, psoriatic arthritis and ulcerative colitis ... Did you know there are some natural JAK/STAT Inhibitors? They’re much weaker than the medications, ...

Rheumatoid arthritis is an autoimmune disease that is characterized by inflammation of the joints and the subsequent destruction of cartilage and erosion of the bone. Patients with rheumatoid ...

Changes in the gut microbiome before rheumatoid arthritis is developed could provide a window of opportunity for preventative treatments, new research suggests.

Rheumatoid arthritis is a common disease affecting an estimated 17 million people worldwide. The disease is caused by immune cells attacking the joints and can result in pain, swelling, and damage to ...

Researchers employed analysis tools and machine learning algorithms to identify two genes linked to rheumatoid arthritis and osteoporosis that could serve as diagnostic tools and potential targets for ...

Researchers found that while some patients showed gut instability, others with stable microbiomes did not progress to ...